Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6765636 | 0.92 | FNTA (1.00) | FNTAFNTB | |
| SCHEMBL6638648 | 0.92 | FNTA (0.88) | FNTAFNTB | |
| SCHEMBL6638181 | 0.91 | FNTA (0.85) | FNTAFNTB | |
| SCHEMBL6769854 | 0.89 | FNTA (1.00) | FNTAFNTB | |
| SCHEMBL6770570 | 0.88 | FNTA (1.00) | FNTAFNTB | |
| SCHEMBL6634393 | 0.86 | FNTA (1.00) | FNTAFNTB | |
| SCHEMBL6637425 | 0.85 | FNTA (0.77) | FNTAFNTB | |
| SCHEMBL13935468 | 0.85 | FNTA (0.92) | FNTAFNTB | |
| SCHEMBL13954623 | 0.84 | FNTA (0.93) | FNTAFNTB | |
| SCHEMBL6636021 | 0.84 | FNTA (0.75) | FNTAFNTB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6699872-B2 | N-substituted urea inhibitors of farnesyl-protein transferase | SCHERING CORPORATION | 2004-03-02 | — | — | US | disclosed |
| US-20020119981-A1 | Novel N-substituted urea inhibitors of farnesyl-protein transferase | REMISZEWSKI STACY W (US) | 2002-08-29 | — | — | US | disclosed |
| US-6358968-B1 | FOR INHIBITING THE ABNORMAL GROWTH OF CELLS | SCHERING CORPORATION | 2002-03-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020119981-A1 | Novel N-substituted urea inhibitors of farnesyl-protein transferase | FNTA, FNTB, UBTF | FNTA 1/4885FNTB 2/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.